Health ProductsType I recall

ACURATE neo2 and ACURATE Prime

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Cardiovascular, Health products - Medical devices - General and plastic surgery
Product: ACURATE neo2 and ACURATE Prime
Issue: Medical devices - Performance
What to do: Contact the manufacturer if you require additional information.
Audience: Healthcare
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected productsLot or serial numberModel or catalogue number
ACURATE Prime ValveAll lots.H74939690250
H74939690270
H74939690230
SYM-SV29-009-C
H74939690290
ACURATE Neo2 Loading KitAll lots.SYM-AC-010
ACURATE Prime Delivery SystemAll lots.H749396822729
H749396822325
SYM-DS-009-C
ACURATE Neo2 Transfemoral Delivery SystemAll lots.SYM-DS-005
SYM-DS-010
ACURATE Prime Loading KitAll lots.H749396942729
SYM-AC-009-C
H749396942325
ACURATE Neo2 ValveAll lots.SYM-SV27-004
SYM-SV23-004
SYM-SV25-004

Issue

Boston Scientific has become aware of new information related to valve underexpansion, that emerged from review of the 1-year clinical trial data from the ACURATE IDE.

Detailed investigation of the 1-year data identified valve underexpansion as a potential leading contributing factor of the missed primary endpoint (ACURATE neo2 non- inferiority to the Control group for the composite of death, stroke and rehospitalisation). ACURATE neo2 valve underexpansion was associated with an increased rate of primary endpoint events compared to cases where the ACURATE neo2 valve was well expanded. However, valve underexpansion was not previously identified through clinical experiences with the ACURATE neo2 valve nor through ACURATE neo2 post market surveillance.

The Instructions for Use (IFU) have been updated to include the risk of valve underexpansion and the practices that may reduce this risk.

Recall start date: November 7, 2024

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime